SEC Filing Details

Document Details

Form
Filing Date
Feb 17, 2026
Document Date
Feb 13, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Sensei Biotherapeutics, Inc
Issuer
SENSEI BIOTHERAPEUTICS, INC.
Filer
DONENBERG PHILLIP B.

MD: 1405 Research Blvd, Suite 125, Rockville, MD 20850

MA: 451 D St, Suite 906,
Boston, MA, 02210